Skip to main content

Advertisement

Log in

Seroprevalence of HTLV-I and HTLV-II infection among immigrants in northern Italy

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

To assess the prevalence of human T cell leukemia virus type 1 (HTLV-I) and 2 (HTLV-II) infection and the associated risk factors among immigrants living in Northern Italy, we surveyed 3017 open-population subjects from three geographical areas and 371 prisoners. In the open population, the overall prevalence was 0.3% for HTLV-I and 0.1% for HTLV-II, while among prisoners, HTLV-I and HTLV-II infection were detected in 1.4 and 0.8% of subjects, respectively. HTLV-I prevalence was higher in subjects with multiple sexual partners or sexually transmitted diseases. This association was significant in the open-population group and close to significance in prisoners. Multivariate analysis showed that human immunodeficiency virus (HIV) seropositivity remained significantly associated with HTLV-I infection in both targeted populations (OR: 11.2 in the open population; OR: 9.9 among prisoners), whereas sexual exposure was associated with HTLV-I seropositivity only for prisoners (OR: 14.3). No independent variable was related to HTLV-II infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Hino S, Yamaguchi K, Katamine S. Mother-to-child transmission of human T cell leukemia virus type-I. Jpn J Cancer Res 1985; 76: 474–480.

    Google Scholar 

  2. Wiktor SZ, Pate EJ, Rosenberg PS, et al. Mother to child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J Hum Virol 1997; 1: 37–44.

    Google Scholar 

  3. Blattner WA. Human lymphotropic viruses: HTLV-I and HTLV-II. In: Richman DD, Whitley RJ, Hayden FG (eds), Clinical virology. New York: Churchill Livingstone, 1997; 683–705.

    Google Scholar 

  4. Tajima K. Worldwide distribution of HTLV. Jpn J Cancer Res 1998; 89: 16–20.

    Google Scholar 

  5. Lairmore MD, Jacobson S, Gracia F, et al. Isolation of human T-cell lymphotropic virus type 2 from Guaymi indians in Panama. Proc Natl Acad Sci USA 1990; 87: 8840–8844.

    Google Scholar 

  6. Froment A, Deleporte E, Dazza M, et al. HTLV-II among Pygmies from Cameroon. AIDS Res Human Retroviruses 1993; 9: 707.

    Google Scholar 

  7. Brennan M, Runganga J, Barbara JA, et al. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. Br Med J 1994; 308: 273–279.

    Google Scholar 

  8. Dalekos GN, Zervou E, Karabini F, et al. Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greece. Transfusion 1995; 35: 503–506.

    Google Scholar 

  9. The HTLV European Research Network. Seroepidemiology of the human T-cell leukemia/lymphoma viruses in Europe. J Acquir Immuno Defic Syndr 1996; 13: 68–77.

    Google Scholar 

  10. Tosswill Jennifer HC, Taylor GP, et al. HTLV-I/II associated disease in England and Wales, 1993-7: Retrospective review of serology requests. Br Med J 2000; 320: 611–612.

    Google Scholar 

  11. Fanin R, Minutillo S, D'Agaro P, et al. HTLV-I positive adult T-cell leukemia-lymphoma: Report of a typical case from Italy. Haematologica 1990; 75: 375–380.

    Google Scholar 

  12. Chironna M, Quarto M, Specchia G, et al. Familiar clustering of HTLV-I infection in southeastern Italy. Lancet 1995; 346: 179–180.

    Google Scholar 

  13. Suligoi B, Galli C, Ciuta S, et al. Low seroprevalence of HTLV-I and HTLV-II in patients witha sexually transmitted disease. Eur J Epidemiol 1999; 15: 225–229.

    Google Scholar 

  14. Giuliani M, Rezza G, Lepri AC, et al. Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases. Sex Transm Dis 2000; 27: 87–92.

    Google Scholar 

  15. Kwok S, Ehrlich G, Poeisz B, et al. Enzymatic amplification of HTLV-I viral sequences from peripheral blood mononuclear cells and infected tissues. Blood 1988; 72: 1117–1123.

    Google Scholar 

  16. Ehrlich G, Greenberg S, Abbott M. Detection of human T-cell lymphoma-leukemia viruses. In: Innis MA, Gelfand DH, Sninskj JJ, Whitte TJ (eds), PCR Protocols, a Guide to Method and Application, Academic Press, 1990.

  17. Department of the Interior. Report of immigration from emergency to programme. www.interno.it.

  18. Vlahov D, Lee H, Taylor E, et al. Antibody to human T-lymphotropic virus I/II among male inmates entering Maryland prisons. J Acquir Immuno Defic Syndr 1990; 3: 531–535.

    Google Scholar 

  19. Manca N, Graifenberghi S, Colombrita D, et al. Antibodies to HTLV-1-2, HIV-1 and HIV-2 in syphilitic patients. Eur J Epidemiol 1990; 6: 201–206.

    Google Scholar 

  20. Christensen PB, Krarup HB, Niesters HG, et al. Prevalence and incidence of bloodborn viral infections among Danish prisoners. Eur J Epidemiol 2000; 16: 1043–1049.

    Google Scholar 

  21. Larsen O, Andersson S, da Silva Z, et al. Prevalence of HTLV-1 infection and associated risk determinants in an urban population in Guinea-Bissau, West Africa. J Acquired Immuno Defic Syndr 2000; 25: 157–163.

    Google Scholar 

  22. Segurado AAC, Malaque CMS, Sumita LM, et al. Laboratory characterization of human T-cell lymphotopic viruses types 1 (HTLV-1) and 2 (HTLV-2) infection in blood donors from Sao Paulo, Brazil. Am J Trop Med Hyg 1997; 57: 142–148.

    Google Scholar 

  23. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999; 353: 1951–1958.

    Google Scholar 

  24. Stephen EH, Foote K, Hendershot GE, et al. Health of the foreign-born population: United States, 1989-1990. Adv data 1994; 241: 1–12.

    Google Scholar 

  25. Trujillo JM, Concha M, Munoz, et al. Seroprevalence and cofactors of HTLV-I infection in Tumaco, Colombia. J Acquir Immuno Defic Syndr Res Hum Retroviruses 1992; 8: 651–657.

    Google Scholar 

  26. Mueller N, Okayama A, Stuver S, et al. Finding from the Miyazaki cohort study. J Acquir Immuno Defic Syndr Hum Retrovirol 1996; 13: 2–7.

    Google Scholar 

  27. Catalan-Soarez BC, Almeida RT, Carneiro-Proietti AB. Prevalence of HIV-1/2, HTLV-I/II, HBV, HCV, Treponema pallidum and Trypanosoma cruzi among prison inmates at Manhuacu, Minas Gerais States, Brazil. Rev Soc Bras Med Trop 2000; 33: 27–30.

    Google Scholar 

  28. Murphy EL. The clinical epidemiology of human Tlymphotropic virus type II (HTLV-II). J Acquir Immuno Defic Syndr Hum Retrovirol 1996; 13S: 215–219.

    Google Scholar 

  29. Lowis GW, Sheremata WA, Minagar A. Epidemiologic feature of HTLV-II. Serological and molecular evidence. Ann Epidemiol 2002; 12: 46–66.

    Google Scholar 

  30. Brites C, Harrington W, Pedroso C, et al. Epidemiological characteristics of HTLV-I and II co-infection in brazilian subjects infected by HIV-1. Braz J Infect 1997; 1: 42–47.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ansaldi, F., Comar, M., D'Agaro, P. et al. Seroprevalence of HTLV-I and HTLV-II infection among immigrants in northern Italy. Eur J Epidemiol 18, 583–588 (2003). https://doi.org/10.1023/A:1024655228893

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024655228893

Navigation